Skip to content
Search

Latest Stories

Theranos founder Elizabeth Holmes found guilty of fraud

Theranos founder Elizabeth Holmes found guilty of fraud

FALLEN US biotech star Elizabeth Holmes was convicted on Monday (3) of defrauding investors in her blood-testing startup Theranos, in a high-profile case seen as an indictment of Silicon Valley culture.

Holmes is a rare example of a tech executive being brought to book over a company flaming out, in a sector littered with the carcasses of money-losing companies that once promised untold riches.


Theranos' former chief operating officer Ramesh "Sunny" Balwani, who has pleaded not guilty is due to stand trial separately for his role in the company's operations. He was indicted in 2018 alongside the Theranos founder.

Holmes’ case shone a spotlight on the blurred line between the hustle that characterises the industry and outright criminal dishonesty.

Jurors took seven days of deliberations to reach their verdict, finding her guilty of four counts of tricking investors into pouring money into what she claimed was a revolutionary testing system.

But the panel - who had listened to weeks of sometimes complex evidence - also acquitted her on four charges and could not reach a verdict on three others.

"The guilty verdicts in this case reflect Ms Holmes' culpability in this large-scale investor fraud and she must now face sentencing for her crimes," US attorney Stephanie Hinds said in a prepared statement read outside the courthouse by a representative.

Holmes, 37, made no comment as she left the court when asked if she intended to appeal.

She now faces the possibility of 20 years behind bars for each conviction. She remains at liberty ahead of another hearing on the terms of her bail next week. No date was set for sentencing.

Elizabeth Holmes Elizabeth Holmes, the founder and former CEO of blood testing and life sciences company Theranos (Photo by NICK OTTO/AFP via Getty Images)

Holmes had vowed to revolutionise health diagnostics with self-service machines that could run an array of tests on just a few drops of blood, a vision that drew high-profile backers and made her a billionaire by the age of 30.

She was hailed as the next tech visionary on magazine covers and collected mountains of investors' cash, but it all collapsed after Wall Street Journal reports revealed the machines did not work as promised.

Prosecutors spent 11 weeks presenting over two dozen witnesses, as they painstakingly laid out their argument that Holmes knew her technology fell short, and deliberately misled investors and patients.

She personally put the logos of pharma giants Pfizer and Schering-Plough onto Theranos reports hailing the company's blood-testing technology, which were then shared with investors.

That was done without the firms' permissions, and was a key piece of the prosecution's argument that she purposely tried to inflate Theranos's credibility in order to win backers.

'Fake it till you make it'

Though big-name Theranos investors like Rupert Murdoch and Henry Kissinger were on the witness list, the most prominent backer to take the stand was ex-Pentagon chief Jim Mattis.

The defence called only one significant witness, Holmes herself, as it argued the fallen entrepreneur had genuinely believed in Theranos's vision, invested herself heavily in its success and had simply failed.

Holmes also sought to shift some of the blame to Balwani, a boyfriend nearly two decades her senior whom she had brought in to help run her company.

She fought back tears as she told jurors that Balwani denigrated her and forced himself on her sexually when angry - accusations that he has strongly denied.

Beyond the company's documents, highly detailed technical questions and Holmes' at-times emotional testimony, there loomed the question of Silicon Valley's very nature.

One of the startup world's most repeated cliches is "fake it till you make it", where ambitious entrepreneurs with an idea that almost works convince people to invest massive sums of money in the hope that one day it will.

It is exceedingly rare for founders of failed Silicon Valley companies - of which there are many - to face fraud prosecution over unrealised promises and unreturned investments.

Some tech world figures, like former Reddit chief Ellen Pao, said sexism may have been a factor in the prosecution, but others argued Holmes had gone too far in trying to prop up her steadily dissolving vision.

After the 2015 Wall Street Journal reports that questioned whether Theranos's machines worked as promised - and ultimately brought down the company - Holmes went on the offensive in the media.

"First they think you're crazy, then they fight you, then all of the sudden you change the world," she said in a TV interview.

(AFP & Reuters)

More For You

CSK vs RCB

CSK and RCB-tune in for this blockbuster clash between two IPL heavyweights

Getty Images

IPL 2025 - CSK vs RCB: Chennai and Bengaluru's clash of titans

The Indian Premier League (IPL) is back with another highly anticipated encounter as Chennai Super Kings (CSK) lock horns with Royal Challengers Bengaluru (RCB) in the 8th match of the 2025 season. The match will take place at the iconic MA Chidambaram Stadium in Chennai on March 28th at 7:30 PM IST. Both teams are coming off strong wins in their previous matches and are eager to extend their winning streaks, making this clash one that fans won’t want to miss.

Team analysis: Chennai Super Kings (CSK)

CSK, one of the most successful franchises in IPL history, comes into this game with confidence after a thrilling victory over Mumbai Indians. Although the chase wasn’t entirely smooth, CSK managed to pull off a win with 4 wickets in hand. Their bowling unit, led by the young sensation Noor Ahmad, was instrumental in restricting Mumbai to a modest total of 155/9. Noor’s outstanding spell of 4 wickets for just 18 runs earned him the well-deserved Man of the Match title, while Khaleel Ahmed also chipped in with 3 wickets.

Keep ReadingShow less
Streeting: Health deal signals new era in UK-India ties

Foreign Office minister Catherine West, health secretary Wes Streeting and equalities minister Seema Malhotra during the Holi Reception in London.

Streeting: Health deal signals new era in UK-India ties

THE recent health and life sciences agreement between the UK and India will strengthen cooperation on healthcare innovation and security in both countries, health secretary Wes Streeting said.

Speaking at the Holi reception organised by the 1928 Institute, who are the secretariat for the India All-Party Parliamentary Group, in London on Monday (24), he added that the contribution of British Indians has been pivotal in the growth of the NHS since its inception in 1948, and a robust partnership between the two nations will ensure we have a healthcare provider 'fit for the future'.

Keep ReadingShow less
Renée Zellweger Joins Only Murders in the Building Season 5 Cast

Renée Zellweger joins the cast of Only Murders in the Building Season 5, bringing more star power to the hit series

Getty Images

Renée Zellweger joins ‘Only Murders in the Building’ season 5 with an expanded star-studded cast

The Oscar-winning actress joins Steve Martin, Selena Gomez, and Martin Short in Hulu’s hit mystery-comedy for an exciting new season.

Renée Zellweger is the latest Hollywood star to join Hulu's hit mystery-comedy Only Murders in the Building for its fifth season. The two-time Academy Award winner will share the screen with series regulars Steve Martin, Martin Short, and Selena Gomez, adding to the show’s already impressive line-up of guest stars.

Keep ReadingShow less
british-steel-iStock

An aerial view of Steel Plant Industry in Scunthorpe. (Photo: iStock)

British Steel to shut blast furnaces, up to 2,700 jobs at risk

BRITISH STEEL, owned by Chinese group Jingye, confirmed on Thursday that it will shut down its blast furnaces and steelmaking operations in England, attributing the decision to market challenges, tariffs, and rising environmental costs.

The closures, first proposed in late 2023, could lead to the loss of up to 2,700 jobs at the company’s main UK site in Scunthorpe, northern England, according to sources familiar with the matter.

Keep ReadingShow less